Profusa, Inc. (PFSA) is up 139.4% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears tied to Profusa’s announcement of a non-binding letter of intent to acquire the PanOmics multi-omics diagnostics platform, marking a strategic expansion beyond its core biosensing business. In a micro-cap stock like PFSA, the combination of a big strategic headline and thin liquidity can amplify price swings.
Details:
Sources:
GlobeNewswire, Investing.com, TipRanks
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$PFSA Hedge Fund Activity
We have seen 7 institutional investors add shares of $PFSA stock to their portfolio, and 12 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 3,475,590 shares (+5203.8%) to their portfolio in Q4 2025, for an estimated $364,241
- GEODE CAPITAL MANAGEMENT, LLC removed 142,219 shares (-98.5%) from their portfolio in Q4 2025, for an estimated $14,904
- TORONTO DOMINION BANK removed 100,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $10,480
- YAKIRA CAPITAL MANAGEMENT, INC. removed 73,631 shares (-98.7%) from their portfolio in Q4 2025, for an estimated $7,716
- RVW WEALTH, LLC added 29,300 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,070
- EWA, LLC added 27,399 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,871
- TWO SIGMA SECURITIES, LLC removed 20,916 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,191
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.